Showing 381-390 of 20873 results for "".
- Leptin's New Role in Diabetic Ketoacidosis Management: Beyond Insulinhttps://reachmd.com/news/leptins-new-role-in-diabetic-ketoacidosis-management-beyond-insulin/2476005/Emerging early-stage research suggests leptin may play a role in managing diabetic ketoacidosis (DKA), but its safety and efficacy compared to insulin require further clinical validation. DKA remains a frequent cause of hospitalization among individuals with type 1 diabetes, placing
- GLP-1RAs Linked with Reduced Itch Prevalence in Diabetes Cohorthttps://reachmd.com/news/glp-1-receptor-agonists-tied-to-reduced-itch-prevalence-in-diabetes-cohort/2485184/Results from a new retrospective cohort analysis suggest some glucagon-like peptide-1 (GLP-1) receptor agonists are associated with a reduced prevalence of itch the type 2 diabetes mellitus (T2DM), independent of glycemic control.
- Inflammatory Diets During Pregnancy Linked to Higher Offspring Diabetes Riskhttps://reachmd.com/news/inflammatory-diets-during-pregnancy-linked-to-higher-offspring-diabetes-risk/2475490/A recent Danish cohort analysis indicates an association between maternal diets high in inflammatory foods and an increased risk of type 1 diabetes in offspring, suggesting a need to reevaluate prenatal nutritional guidance. According
- Lifestyle Interventions and Diabetes Prevention: Planning, Tracking, and Mindful Livinghttps://reachmd.com/news/lifestyle-interventions-and-diabetes-prevention-planning-tracking-and-mindful-living/2474656/Comprehensive lifestyle interventions incorporating strategic planning, progress tracking, and mindfulness are significantly reducing the risk of type 2 diabetes. With evidence indicating that nearly 38% of U.S. adults are affected by
- Study: Test Improves the Risk Stratification of Patients with Stage I Melanomahttps://reachmd.com/news/study-finds-decisiondx-melanoma-significantly-improves-the-risk-stratification-of-patients-with-stage-i-melanoma-compared-to-american-joint-committee-on-cancer-8th-edition-staging/2462252/Results from a recent study showed the potential of a 31-gene expression profile (31-GEP) test in improving the prognosis for patients diagnosed with stage I cutaneous melanoma. Despite being considered at low risk for metastasis or melanoma-specific death, patients with stage I cutaneous
- Exploring the Ocular Benefits of GLP-1 Receptor Agonists in Type 2 Diabetes Managementhttps://reachmd.com/news/exploring-the-ocular-benefits-of-glp-1-receptor-agonists-in-type-2-diabetes-management/2471688/GLP-1 Receptor Agonists: A Novel Protective Agent Against Glaucoma in Diabetic Patients? Recent investigations have highlighted that beyond their well-known effects on glycemic control, GLP-1 receptor agonists may significantly reduce the risk of developing primary
- BMI and Hematocrit Predict ESRD Risk in Type 2 Diabeteshttps://reachmd.com/news/bmi-and-hematocrit-predict-esrd-risk-in-type-2-diabetes/2488225/Key Takeaways Among adults with T2DM followed for 3 years at a Shanghai center, 16% progressed to ESRD. Higher BMI was associated with greater renal failure risk across both the multivariable MR analysis and the retrospective clinical cohort. Higher hematocr
- Retatrutide Lowers A1C and Weight in Phase 3 Type 2 Diabetes Trialhttps://reachmd.com/news/retatrutide-a1c-weight-phase-3-type-2-diabetes-trial/2487636/Key Takeaways Retatrutide was associated with larger HbA1c reductions than placebo at all evaluated doses over 40 weeks. Body weight decreased more with retatrutide than with placebo during the same 40-week period. Gastrointestinal events were
- Oral HRS-7535 Lowers HbA1c in Metformin-Treated Type 2 Diabeteshttps://reachmd.com/news/oral-hrs-7535-lowers-hba1c-in-metformin-treated-type-2-diabetes/2487369/Key Takeaways All active HRS-7535 doses were associated with greater HbA1c reduction than placebo at week 16, with placebo-adjusted differences ranging from -0.94% to -1.57%. Higher proportions reached HbA1c below 7.0%, fasting and 2-hour postprandial
- Achieving Optimal Cardiovascular Health to Reduce Dementia Risk in Type 2 Diabeteshttps://reachmd.com/news/achieving-optimal-cardiovascular-health-to-reduce-dementia-risk-in-type-2-diabetes/2484364/A preliminary study being presented at the American Heart Association (AHA) Scientific Sessions suggests that amon